ArticleDigestive diseases and sciences2026
Collagenous Gastritis in Adults: A Case Series Elucidating the Potential Overlap with Eosinophilic Gastritis.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Pediatric Eosinophil-Predominant Collagenous Gastritis: From Conventional Therapy to Dupilumab: A Case Report.Reports (MDPI) · 2026Article
- Chronic Diarrhea and Weight Loss in a 27-Year-Old: Highlighting Collagenous Gastritis as a Rarely Encountered Entity.Diagnostics (Basel, Switzerland) · 2026Article
- The Plot Thickens - Is Eosinophilic Gastritis Related to Collagenous Gastritis?Digestive diseases and sciences · 2026Article
- Collagenous gastritis: current understanding of a rare immune-mediated gastropathy across pediatric and adult phenotypes-from pathogenesis to therapeutic strategies.Frontiers in cell and developmental biology · 2026Review
- Eosinophilic and mastocytic gastrointestinal diseases: current knowledge and controversy in histopathologic diagnosis.Translational gastroenterology and hepatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCollagenous gastritis (CoG) is a rare disorder defined by subepithelial collagen deposition in the gastric mucosa, with associated lymphocytic or eosinophilic infiltrates in some reported cases. PURPOSE: Our case series seeks to describe the clinical course of CoG in adults after treatment and associated endoscopic and histopathologic changes over time, specifically overlap with eosinophilic gastritis (EoG).
methodsThis case series includes eight patients diagnosed with CoG as adults at a single, large, academic tertiary care center between 2020 and 2024. Patient data were obtained through a retrospective chart review.
resultsThe mean age at diagnosis was 34 years, 50% were female, and 75% identified as White. Most reported abdominal pain, dyspepsia, and a recent history of gastrointestinal bleeding. Notably, all the eight patients were found to meet a concurrent EoG diagnosis on secondary retrospective review of the initial index CoG diagnosis biopsies. The majority had symptom improvement with budesonide and/or proton pump inhibitor (PPI) treatment. An elimination diet helped improve symptoms for 50% of the patients. However, only 25% had confirmed histopathologic improvement in collagen deposition.
conclusionsOur case series suggests an apparent strong association between adult-onset CoG and EoG, raising the possibility that they may in fact be part of a disease spectrum and that chronic eosinophilic inflammation progresses to collagen deposition. Given a lack of established treatment guidelines for CoG, our study suggests that in addition to PPI and steroid treatments, an elimination diet may also be beneficial along with other EoG therapeutic modalities.
Indexed as
Identifiers
40849870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.